Commenting on Paraneoplastic Arthritides: Insights to Pathogenesis, Diagnostic Approach, and Treatment
- PMID: 33961356
- DOI: 10.1097/RHU.0000000000001448
Commenting on Paraneoplastic Arthritides: Insights to Pathogenesis, Diagnostic Approach, and Treatment
Conflict of interest statement
The authors declare no conflict of interest.
Comment in
-
Response to: Paraneoplastic Arthritides: Insights to Pathogenesis, Diagnostic Approach, and Treatment.J Clin Rheumatol. 2021 Dec 1;27(8S):S887. doi: 10.1097/RHU.0000000000001449. J Clin Rheumatol. 2021. PMID: 35073645 No abstract available.
Comment on
-
Paraneoplastic Arthritides: Insights to Pathogenesis, Diagnostic Approach, and Treatment.J Clin Rheumatol. 2021 Dec 1;27(8):e505-e509. doi: 10.1097/RHU.0000000000001202. J Clin Rheumatol. 2021. PMID: 31743270 Review.
References
-
- Parperis K, Constantinidou A, Panos G. Paraneoplastic arthritides: insights to pathogenesis, diagnostic approach, and treatment. J Clin Rheumatol . 2019.
-
- Bellan M, Boggio E, Sola D, et al. Association between rheumatic diseases and cancer: results from a clinical practice cohort study. Intern Emerg Med . 2017;12:621–627.
-
- Muller S, Hider S, Helliwell T, et al. The real evidence for polymyalgia rheumatica as a paraneoplastic syndrome. Reumatismo . 2018;70:23–34.
-
- Ungprasert P, Sanguankeo A, Upala S, et al. Risk of malignancy in patients with giant cell arteritis and polymyalgia rheumatica: a systematic review and meta-analysis. Semin Arthritis Rheum . 2014;44:366–370.
-
- Pease CT, Haugeberg G, Montague B, et al. Polymyalgia rheumatica can be distinguished from late onset rheumatoid arthritis at baseline: results of a 5-yr prospective study. Rheumatology (Oxford) . 2009;48:123–127.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
